PTPRC and glioblastoma: To study immune states associated with purine signaling, we evaluated an additional scRNA-seq dataset from a recently published database of 7 newly-diagnosed and 4 recurrent/residual glioblastomas comprising 21,303 and 42,870 FACS-sorted CD45-positive immune cells, respectively51.